Declared technologies base

TRANSFER OF INNOVATIONAL TECHNOLOGIES

COLD-PLASMA ARGON COAGULATOR


Purpose of the development: To be used medical institutions of different types, including military-field and emergency surgeries. Stopping bleeding with simultaneous antiseptic treatment in major surgeries, including those on internal organs. Decreasing time needed to heat vulnerary complications occurring in the post-operation period, stimulating trauma and burn vulnerary defects heating.

Recommended application field: Medicineю

Technical characteristic: A new kind of product with improved consumer properties, featuring a broad range of functional capabilities. It has definite market potential.

Advantages over analogues: The device exceeds its analogues produced by the Erbe (the USA) Vallilab (Germany) by such parameters as compactness, simple and safe operation, with cost much lower. Pronounced sterilizing effect (on the wound treatment the amount of microorganisms goes down by 4 - 6 orders). Wounds heal faster (4 to 6 days earlier than of patients in the reference group) and without complications.

The development stage readiness: Introduced in production

Description of the development:
()
The device consists of a generator (the main unit), remove head (plasmatron) gas-dynamic unit (a high-pressure vessel with a reducing valve), control foot pedal. The plasmatron incorporates a high-frequency unipole resonance generator of high voltage, a point electrode with a gas-feeding tube coaxially joint to it and an injector nozzle. The operation principle of the device is based upon pulse-periodic excitation and ionization of the inert gas jet outgoing from the nozzle and generation of electric spark discharge pulses with unipole high-frequency voltage. It results in formation of a multispark cold-plasma flare on the tip of the plasmatron active electrod. The cold-plasma flare characteristics are determined by parameters of the generator work mode (voltage and frequency), the nozzle sizes design of the high-voltage converter. The device enables to smoothly regulate the depth of living tissues treatment (from a micron up to tenths of a millimeter) limiting heat affect on adjacent areas of living tissues. It permits to reduce pain and stop bleeding with in a minimum period of time. The device is protected by RF patent # 2138213 of 27.09.1999.

Information about newness of the development:
there are Ukrainian patents -- 1 items

Possibility of transfer abroad:
Licence's sale
Licence's sale
Creation of joint enterprise
Joint production, sale, exploitation

Photo

Country Russia

For additional information turn to:
E-mail: gal@uintei.kiev.ua

or fill out the form:
Organization name :
Address :
Settlement account :
Bank :
MFO :
OKPO code :

Scientific organization tutor's data :
Surname :
Name :
Patronymic :
Scientific degree :
Phone :
Fax :
E-mail :
Cooperation proposals (joint patent, joint enterprise, assembly sale and so on :
country: